@article{ATM20836,
author = {Clifford Akateh and Timothy M. Pawlik and Jordan M. Cloyd},
title = {Adjuvant antiviral therapy for the prevention of hepatocellular carcinoma recurrence after liver resection: indicated for all patients with chronic hepatitis B?},
journal = {Annals of Translational Medicine},
volume = {6},
number = {20},
year = {2018},
keywords = {},
abstract = {Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide with an increasing incidence that affects all major demographic groups (1,2). Hepatitis B virus (HBV) infection is a major risk factor and leading cause of HCC development, accounting for approximately 33% of HCC cases worldwide (and up to 2/3 of cases in under-developed countries) (3,4).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/20836}
}